Bayer/Janssen seek Xa inhibitor antidote

February 6, 2013
Research and Development, Sales and Marketing Bayer, Janssen, PRT4445, Xarelto

Bayer HealthCare and Janssen Pharmaceuticals have signed a deal with Portola Pharmaceuticals to evaluate the safety of an investigational antidote …

GSK image

GSK announces AllTrials support

February 6, 2013
Research and Development, Sales and Marketing ABPI, Bad pharma, GSK, Goldacre

GlaxoSmithKline has this morning found itself in the unusual position of being showered with praise by one of its fiercest …

screen_shot_2013-02-05_at_14

Aesica recruits operations director

February 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Aesica, CMO

Contract manufacturing organisation (CMO) Aesica has appointed Jarrett Palmer as Operations director of its formulated products business unit business. Palmer …

Sanofi celebrates EU approvals

February 5, 2013
Sales and Marketing Lyxumia, Sanofi, Zaltrap, diabetes

Sanofi is celebrating after diabetes treatment Lyxumia (lixisenatide) and metastatic colorectal cancer (mCRC) drug Zaltrap received authorisation in Europe. The …

lennernas_2

Recipharm appoints Hans Lennernäs to operating Board

February 5, 2013
Manufacturing and Production, Research and Development, Sales and Marketing Recipharm

Recipharm Pharmaceutical Development AB has announced the appointment of Dr Hans Lennernäs to the company’s Board of directors. Lennernäs is …

ABPI image

GP concern over GMC guidance

February 5, 2013
Sales and Marketing ABPI, GMC, GP, NHS

The ABPI has ‘warmly’ welcomed the new prescribing guidance from the General Medical Council – but GPs are far from …

Shanghai image

SFDA publishes high-risk excipients list

February 5, 2013
Manufacturing and Production China, GMP, SFDA

China’s State Food and Drug Administration (SFDA) has published a list of 28 excipients which are considered high-risk and therefore …

Langland image

Langland triumph again at PM Society Ad Awards

February 4, 2013
Medical Communications, Sales and Marketing awards. langland, pm society

Langland Advertising swept the board for the third time in four years at the PM Society Advertising Awards, held on …

Roche image

Facility of the year: 2013 winners announced

February 4, 2013
Manufacturing and Production Biogen, MedImmune, Merck, Novartis, Roche

Three US and three European manufacturing plants have been selected as category winners for the annual Facility of the Year …

Hunt image

Hunt pledges ‘paperless NHS’

February 4, 2013
Sales and Marketing DH, Hunt, NHS, paperless

Health secretary Jeremy Hunt has put his head on the block by pledging that moves towards a ‘paperless NHS’ will …

USP rejects appeals on elemental impurities update

February 4, 2013
Manufacturing and Production USP

The US Pharmacopeial Convention (USP) has rejected an appeal by drugmakers and suppliers of pharmaceutical ingredients to postpone publication of …

Pharma manufacturing news in brief

February 4, 2013
Manufacturing and Production ACS, Amcor, Beanne, Iogen Bio-products, Novozymes, Pluristem

Facility investments from Amcor and Pluristem, Beanne Chemical falls foul of FDA inspectors, Novozymes acquisition plus a green chemistry app.

lilly image

Survey shock for pharma

February 4, 2013
Medical Communications, Research and Development, Sales and Marketing Cancer, PACE, lilly, pharma, research

A survey released to tie in with today’s World Cancer Day finds that most people feel pharma companies see cancers …

dalton

NHS Commissioning Board executive departs

February 4, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing CB, Dalton, NHS

The NHS Commissioning Board has announced the forthcoming departure of its chief operating officer and deputy chief executive. Ian Dalton …

Lewisham image

Lewisham A&E spared axe

February 1, 2013
Sales and Marketing Hunt, Lewisham, Miliband, NHS

The government’s threat to close Lewisham Hospital’s A&E unit has been lifted after health secretary Jeremy Hunt decided to cut …

Forxiga image

NICE rejects Forxiga

February 1, 2013
Sales and Marketing AstraZeneca, BMS, Forxiga, NICE, diabetes

NICE has given the thumbs-down to AstraZeneca and Bristol-Myers Squibb’s first-in-class type II diabetes treatment Forxiga. The drug was approved …

andrew_ajello_-large

Novo Nordisk creates four senior vice presidents

February 1, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novo Nordisk

Novo Nordisk has promoted four corporate vice presidents within its ranks into senior vice presidents.  The following members of the US …

GSK slams Guardian article

January 31, 2013
Sales and Marketing Avandia, FDA, GSK, Guardian

GlaxoSmithKline has slammed an article about its controversial diabetes treatment Avandia in The Guardian newspaper, saying that some of it …

NHS image

NHS expertise sold abroad

January 31, 2013
Sales and Marketing NHS, UK, government, outsourcing

The government has set up an organisation which will seek to maximise revenue from foreign firms and governments for the …

Lilly hit by Zyprexa losses

January 30, 2013
Sales and Marketing antipsychotic, lilly, zyprexa

The loss of exclusivity on Eli Lilly’s blockbuster antipsychotic Zyprexa hit the company hard in 2012, with the firm’s overall …

The Gateway to Local Adoption Series

Latest content